Older age was an important risk factor for invasive mold infections after alloSCT.
Other risk factors included treatment with mesenchymal stromal cells and graft-versus-host disease.
In patients with graft-versus-host disease grade II, no invasive mold infections were seen in patients < 40 years of age compared with 14% in patients > 40 years of age.